NeMO mutations: a rare cause of monogenic Behçet-like disease

Rheumatology (Oxford). 2021 Mar 2;60(3):e92-e94. doi: 10.1093/rheumatology/keaa505.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adalimumab / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Behcet Syndrome / drug therapy
  • Behcet Syndrome / genetics*
  • Child, Preschool
  • Colchicine / therapeutic use
  • Female
  • Humans
  • I-kappa B Kinase / genetics*
  • I-kappa B Kinase / immunology
  • Incontinentia Pigmenti / drug therapy
  • Incontinentia Pigmenti / genetics
  • Mutation
  • Prednisone / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • IKBKG protein, human
  • I-kappa B Kinase
  • Adalimumab
  • Colchicine
  • Prednisone